Outpatient Hystroscopy of Kasr El Ainy
Giza, 12521, Egypt
NCT Number: NCT03747692
Single blind randomized controlled study in which 80 patients coming for hystroscopy due to multiple indication as infertility, AUB and missed IUD were assigned for our study. Both Sample size and randomization were done by a computer program. Patients were classified into 2 groups, group 1 study group was subjected to intracervical injection of 5 mi of mepivacaine hydrochloride at position 3 and 9 of the vaginal portion of the cervix, and at least 5 minutes post injection before procedure done. The control group received NSAI injection 15 minutes before procedure and 5 ml of saline was injected in each side of cervix at 3 9 positions. Hystroscopy was done if an abnormality is detected an intervention was done. A descriptive scale of pain was done into mild, moderate or severe (that lead to interruption of the procedures).
Looking for future studies?
Notify MeUp to 40 year
Female
Interventional
Not applicable
Giza, 12521, Egypt
Procedures:
All patients were subjected to:
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
local anesthesia by mepicaine hydrochloride by intracervical local injection using 10 mm syringe.
each patient receives one tablet of NSAIDs (diclofenac sodium 50 mg) and 5ml of a placebo in form of normal saline are injected intracervical 5 minutes before the procedure using 10 mm syringe.
Time frame: 30 minutes
complete hystroscopy procedure with tolerable degree of pain.
Time frame: 30 minutes
symptoms of vasovagal as vomiting , sweeting and bradycardia
Cairo University
Other
Cairo University Faculty of Medicine
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06139757
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Chicago, Illinois, United States
View Trial DetailsNCT03712982
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Waltham, Massachusetts, United States
View Trial DetailsNCT05698550
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Jinan, Shandong, China
View Trial DetailsNCT03349905
Endometriosis, Female Urogenital Diseases
Paris, France
View Trial Details